NMPA Approval

Levetiracetam Concentrated Solution for Injection

Approval Number

国药准字H20233679

Company呋欧医药科技（湖州）有限公司

Registration Date

June 7, 2023

Drug Information

Generic Name

左乙拉西坦注射用浓溶液

Dosage Form

注射剂

Strength

5ml:500mg

Drug Type

化学药品

Registration Date

June 7, 2023

Company Information

Applicant Company

Company Name呋欧医药科技（湖州）有限公司

Company Address

浙江省湖州市湖州经济技术开发区龙溪街道王母山路1800号1号楼二层207

Manufacturing Company

Company Name浙江康恩贝制药股份有限公司

Company Address

浙江省兰溪市康恩贝大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

左乙拉西坦注射用浓溶液 - NMPA 批准文号 | MedPath